| ID: | 89424 | |
| Title: | BRAF v600e | |
| URL: | http://www.clarientinc.com/ | |
| Category: | Health: Health Care | |
| Description: | The BRAF (V600E) mutation analysis is predictive for anti-EGFR therapies (i.e., cetuximab and panitumumab). BRAF mutations account for approximately 12-15% of colorectal cancer patients. | |
| Pagerank: | 5 | |